154 related articles for article (PubMed ID: 7952793)
1. Dose-related protection against histamine-induced bronchoconstriction by inhaled salmeterol.
Maconochie JG; Denyer LH; Hassani H
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):329-34. PubMed ID: 7952793
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction.
Schaanning J; Vilsvik J; Henriksen AH; Bratten G
Ann Allergy Asthma Immunol; 1996 Jan; 76(1):57-60. PubMed ID: 8564629
[TBL] [Abstract][Full Text] [Related]
3. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082
[TBL] [Abstract][Full Text] [Related]
4. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
Solèr M; Joos L; Bolliger CT; Elsasser S; Perruchoud AP
Eur Respir J; 1994 Nov; 7(11):1973-7. PubMed ID: 7875267
[TBL] [Abstract][Full Text] [Related]
5. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
[TBL] [Abstract][Full Text] [Related]
6. Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.
Koskela HO; Kiviniemi V; Purokivi MK; Taivainen AH; Tukiainen HO
Respir Med; 2006 Oct; 100(10):1760-6. PubMed ID: 16563715
[TBL] [Abstract][Full Text] [Related]
7. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
Britton MG; Earnshaw JS; Palmer JB
Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
[TBL] [Abstract][Full Text] [Related]
8. [Bronchodilator effect of salmeterol and inhibition of bronchial hyperreactivity].
Boulet LP
Rev Mal Respir; 1992; 9 Suppl 1():R11-3. PubMed ID: 1350363
[TBL] [Abstract][Full Text] [Related]
9. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
[TBL] [Abstract][Full Text] [Related]
10. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
Gongora HC; Wisniewski AF; Tattersfield AE
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of salmeterol in patients with allergic bronchial asthma].
Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
[TBL] [Abstract][Full Text] [Related]
12. Overnight protection by inhaled salmeterol on exercise-induced asthma in children.
Carlsen KH; Røksund O; Olsholt K; Njå F; Leegaard J; Bratten G
Eur Respir J; 1995 Nov; 8(11):1852-5. PubMed ID: 8620951
[TBL] [Abstract][Full Text] [Related]
13. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
Simons FE; Soni NR; Watson WT; Becker AB
J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
[TBL] [Abstract][Full Text] [Related]
14. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
15. [The influence of salmeterol and salbutamol on bronchial constriction in patients with bronchial asthma].
Tymińska K; Grzelewska-Rzymowska I; Kroczyńska-Bednarek J; Kwiatkowska S
Pneumonol Alergol Pol; 1998; 66(11-12):524-9. PubMed ID: 10391959
[TBL] [Abstract][Full Text] [Related]
16. TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol in conscious guinea-pigs.
Turner DL; Ferrari N; Ford WR; Kidd EJ; Paquet L; Renzi P; Broadley KJ
Eur J Pharmacol; 2010 Sep; 641(2-3):213-9. PubMed ID: 20639142
[TBL] [Abstract][Full Text] [Related]
17. [Duration of bronchial protective effect of salmeterol in asthma induced by hyperventilation with dry cold air].
Malo JL; Cartier A; Ghezzo H; Trudeau C; L'Archevêque J
Rev Mal Respir; 1992; 9 Suppl 1():R19-21. PubMed ID: 1350365
[TBL] [Abstract][Full Text] [Related]
18. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
Derom EY; Pauwels RA; Van der Straeten ME
J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164
[TBL] [Abstract][Full Text] [Related]
19. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours.
Nowak D; Jörres R; Rabe KF; Lüthke M; Wiessmann J; Magnussen H
Eur J Clin Pharmacol; 1992; 43(6):591-5. PubMed ID: 1493839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
